
(1S,2S)-Bortezomib ;
Bortezomib USP Impurity G ;
Bortezomib (S,S)-Diastereomer (USP) ;
[(1S)-3-Methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid ;
CAS # 1132709-14-8 ;
C19H25BN4O4 ;
MW: 384.24 ;
(1S,2S)-Bortezomib ;
Bortezomib USP Impurity G ;
Bortezomib (S,S)-Diastereomer (USP) ;
[(1S)-3-Methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid ;
CAS # 1132709-14-8 ;
C19H25BN4O4 ;
MW: 384.24 ;